724 related articles for article (PubMed ID: 31660074)
1. A tumor microenvironment responsive biodegradable CaCO
Liu Y; Pan Y; Cao W; Xia F; Liu B; Niu J; Alfranca G; Sun X; Ma L; de la Fuente JM; Song J; Ni J; Cui D
Theranostics; 2019; 9(23):6867-6884. PubMed ID: 31660074
[TBL] [Abstract][Full Text] [Related]
2. Pd@Au Bimetallic Nanoplates Decorated Mesoporous MnO
Zhang Y; Lv F; Cheng Y; Yuan Z; Yang F; Liu C; Cao Y; Zhang K; Lu H; Zada S; Guo S; Dong H; Zhang X
Adv Healthc Mater; 2020 Jan; 9(2):e1901528. PubMed ID: 31820854
[TBL] [Abstract][Full Text] [Related]
3. Hollow MnO
Yang G; Xu L; Chao Y; Xu J; Sun X; Wu Y; Peng R; Liu Z
Nat Commun; 2017 Oct; 8(1):902. PubMed ID: 29026068
[TBL] [Abstract][Full Text] [Related]
4. Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy.
Zhou Z; Liu Y; Song W; Jiang X; Deng Z; Xiong W; Shen J
J Control Release; 2022 Dec; 352():793-812. PubMed ID: 36343761
[TBL] [Abstract][Full Text] [Related]
5. O
Lin T; Zhao X; Zhao S; Yu H; Cao W; Chen W; Wei H; Guo H
Theranostics; 2018; 8(4):990-1004. PubMed ID: 29463995
[TBL] [Abstract][Full Text] [Related]
6. Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy.
Xiong W; Qi L; Jiang N; Zhao Q; Chen L; Jiang X; Li Y; Zhou Z; Shen J
ACS Appl Mater Interfaces; 2021 Feb; 13(7):8026-8041. PubMed ID: 33577301
[TBL] [Abstract][Full Text] [Related]
7. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable Hollow Polydopamine@manganese Dioxide as an Oxygen Self-Supplied Nanoplatform for Boosting Chemo-photodynamic Cancer Therapy.
Wang H; Wang W; Liu L; Wang M; Li G; Li H; Li B; Yu S; Ma D; Xue W
ACS Appl Mater Interfaces; 2021 Dec; 13(48):57009-57022. PubMed ID: 34806877
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional nanoplatform for enhanced photodynamic cancer therapy and magnetic resonance imaging.
Hao Y; Zhang B; Zheng C; Niu M; Guo H; Zhang H; Chang J; Zhang Z; Wang L; Zhang Y
Colloids Surf B Biointerfaces; 2017 Mar; 151():384-393. PubMed ID: 28029550
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment responsive hollow mesoporous Co
Huang J; Huang Y; Xue Z; Zeng S
Biomaterials; 2020 Dec; 262():120346. PubMed ID: 32927232
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Cellular Ablation by Attenuating Hypoxia Status and Reprogramming Tumor-Associated Macrophages via NIR Light-Responsive Upconversion Nanocrystals.
Ai X; Hu M; Wang Z; Lyu L; Zhang W; Li J; Yang H; Lin J; Xing B
Bioconjug Chem; 2018 Apr; 29(4):928-938. PubMed ID: 29466856
[TBL] [Abstract][Full Text] [Related]
12. Immune/Hypoxic Tumor Microenvironment Regulation-Enhanced Photodynamic Treatment Realized by pH-Responsive Phase Transition-Targeting Nanobubbles.
Zhao M; Yang X; Fu H; Chen C; Zhang Y; Wu Z; Duan Y; Sun Y
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32763-32779. PubMed ID: 34235912
[TBL] [Abstract][Full Text] [Related]
13. Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief.
He M; Zhang M; Xu T; Xue S; Li D; Zhao Y; Zhi F; Ding D
J Control Release; 2024 Apr; 368():233-250. PubMed ID: 38395154
[TBL] [Abstract][Full Text] [Related]
14. MnO
Li B; Wang X; Hong S; Wang Q; Li L; Eltayeb O; Dong C; Shuang S
Food Funct; 2021 Jul; 12(14):6334-6347. PubMed ID: 34100053
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional nanoplatform based on g-C
Li M; Xiao M; Pan Q; Xiong J
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102684. PubMed ID: 34923155
[TBL] [Abstract][Full Text] [Related]
16. Immune Checkpoint Blockade Mediated by a Small-Molecule Nanoinhibitor Targeting the PD-1/PD-L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer.
Zhang R; Zhu Z; Lv H; Li F; Sun S; Li J; Lee CS
Small; 2019 Dec; 15(49):e1903881. PubMed ID: 31702880
[TBL] [Abstract][Full Text] [Related]
17. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
18. DNAzyme-Assisted Nano-Herb Delivery System for Multiple Tumor Immune Activation.
Du S; Chen C; Qu S; Song H; Yang J; Li Y; Liu K; Lu Q; Luo W; Wang R; Guan X; Song Y; Han X
Small; 2022 Nov; 18(45):e2203942. PubMed ID: 36156383
[TBL] [Abstract][Full Text] [Related]
19. Intelligent MnO
Cao Y; Meng X; Wang D; Zhang K; Dai W; Dong H; Zhang X
ACS Appl Mater Interfaces; 2018 May; 10(21):17732-17741. PubMed ID: 29737836
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin and siRNA-PD-L1 co-delivery with T7 modified ROS-sensitive nanoparticles for tumor chemoimmunotherapy.
Wan WJ; Qu CX; Zhou YJ; Zhang L; Chen MT; Liu Y; You BG; Li F; Wang DD; Zhang XN
Int J Pharm; 2019 Jul; 566():731-744. PubMed ID: 31212055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
